NCT07512869 Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study
| NCT ID | NCT07512869 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of HIV Research and Innovation Foundation, Thailand |
| Condition | HIV Prevention |
| Study Type | OBSERVATIONAL |
| Enrollment | 76 participants |
| Start Date | 2025-02-17 |
| Primary Completion | 2027-02-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 76 participants in total. It began in 2025-02-17 with a primary completion date of 2027-02-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the pre-implementation phase of a host-led harm reduction model for men who have sex with men (MSM) engaging in chemsex in Bangkok, Thailand, focusing on understanding harms, contexts, and needs to develop a tailored intervention.
Eligibility Criteria
Inclusion Criteria: * MSM aged ≥18 years * Able to communicate in Thai * Specific by group: * Chemsex hosts: hosted ≥2 times in past 6 months * Chemsex guests: attended ≥2 times in past 6 months * CSO / hospital / police staff: working ≥3 months in related roles * Provide informed consent Exclusion Criteria: • Unable to provide informed consent (e.g., under substance influence at consent)
Contact & Investigator
Jakkrapatara Boonruang, MD
PRINCIPAL INVESTIGATOR
Institute of HIV Research and Innovation (IHRI)
Frequently Asked Questions
Who can join the NCT07512869 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying HIV Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07512869 currently recruiting?
Yes, NCT07512869 is actively recruiting participants. Contact the research team at nittaya.p@ihri.org for enrollment information.
Where is the NCT07512869 trial being conducted?
This trial is being conducted at Pathum Wan, Thailand.
Who is sponsoring the NCT07512869 clinical trial?
NCT07512869 is sponsored by Institute of HIV Research and Innovation Foundation, Thailand. The principal investigator is Jakkrapatara Boonruang, MD at Institute of HIV Research and Innovation (IHRI). The trial plans to enroll 76 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.